Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Medicale (MCLE) EPS (Weighted Average and Diluted) (2021 - 2025)

Medicale (MCLE) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with -$0.01 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, EPS (Weighted Average and Diluted) changed N/A year-over-year to -$0.01, compared with a TTM value of -$0.01 through Jun 2025, changed N/A, and an annual FY2023 reading of $0.0, up 118.96% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.01 for Q2 2025 at Medicale, down from -$0.0 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.0 in Q4 2022 and bottomed at -$0.01 in Q2 2025.
  • Average EPS (Weighted Average and Diluted) over 4 years is -$0.0, with a median of -$0.0 recorded in 2025.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 175.83% in 2022, while the deepest fall reached 91.32% in 2022.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.0 in 2021, then surged by 175.83% to $0.0 in 2022, then plummeted by 3395.6% to -$0.0 in 2024, then plummeted by 294.8% to -$0.01 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for MCLE at -$0.01 in Q2 2025, -$0.0 in Q1 2025, and -$0.0 in Q4 2024.